Skip to main content

Table 4 Correlation of HER-2 expression and MMR status in 2031 GC patients

From: Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer

Variables

p-MMR

d-MMR

p value

HER-2 3+

75/2031 (3.7%)

2/2031 (0.1%)

0.129

HER-2 0/1+/2+

1816/2031 (89.4%)

138/2031 (6.8%)

Â